Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Invested Capital (2016 - 2017)

Bone Biologics has reported Invested Capital over the past 3 years, most recently at -$8.4 million for Q4 2017.

  • Quarterly Invested Capital fell 17.2% to -$8.4 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$8.4 million through Dec 2017, down 17.2% year-over-year, with the annual reading at -$8.4 million for FY2017, 17.2% down from the prior year.
  • Invested Capital was -$8.4 million for Q4 2017 at Bone Biologics, down from $2.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $5.8 million in Q1 2016 and troughed at -$8.4 million in Q4 2017.
  • The 3-year median for Invested Capital is $2.5 million (2017), against an average of $141692.0.
  • Year-over-year, Invested Capital crashed 70.65% in 2016 and then surged 33.42% in 2017.
  • A 3-year view of Invested Capital shows it stood at -$4.2 million in 2015, then crashed by 70.65% to -$7.2 million in 2016, then decreased by 17.2% to -$8.4 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Invested Capital are -$8.4 million (Q4 2017), $2.7 million (Q3 2017), and $2.5 million (Q2 2017).